Fowlie P W, Gould C R, Tarnow-Mordi W O, Strang D
Department of Child Health, University of Dundee, UK.
Crit Care Med. 1998 Jan;26(1):163-8. doi: 10.1097/00003246-199801000-00033.
Clinical Risk Index for Babies (CRIB) is a simple instrument used to measure clinical risk and illness severity in very low birth-weight infants. We assessed its reliability, validity beyond the first 12 hrs after birth, and responsiveness to individual change in condition after 7 days.
Cohort study.
Three tertiary and three nontertiary UK hospitals.
Three hundred ninety-eight infants whose birth weight was <1501 g or who were born before a 31-wk gestation period.
Inter- and intrarater reliability of data extraction were assessed by Pearson and intraclass correlation. To validate CRIB, we tested the correlation between clinical risk and illness severity with the risk of: a) death; b) prolonged treatment with supplemental oxygen; and c) disability at 2 yrs. Logistic regression models were fitted to assess validity and responsiveness.
Reliability coefficients ranged from 0.76 (95% confidence interval, 0.71 to 0.81) to 0.97 (0.94 to 1.00). Throughout the first week, CRIB correlated with the risk of death (p < .001), prolonged treatment with oxygen (p < .001), and disability (p < .001 to p = .033). Improved condition, represented by a reduction in CRIB within the first week, was independently associated with lower risks of each adverse outcome, p < .05.
During the first week, CRIB was reliable, valid, and responsive. These properties support the use of CRIB in the stratification of infants by risk and illness severity in cohort studies, and they also indicate that CRIB may have the potential to be used in other ways in the future.
婴儿临床风险指数(CRIB)是一种用于测量极低出生体重儿临床风险和疾病严重程度的简易工具。我们评估了其可靠性、出生后12小时后的有效性以及7天后对个体病情变化的反应性。
队列研究。
英国的三家三级医院和三家非三级医院。
398名出生体重<1501克或孕周<31周的婴儿。
通过Pearson相关系数和组内相关系数评估数据提取的评分者间和评分者内可靠性。为验证CRIB,我们测试了临床风险和疾病严重程度与以下风险之间的相关性:a)死亡;b)长期补充氧气治疗;c)2岁时的残疾情况。采用逻辑回归模型评估有效性和反应性。
可靠性系数范围为0.76(95%置信区间,0.71至0.81)至0.97(0.94至1.00)。在第一周内,CRIB与死亡风险(p<.001)、长期氧气治疗风险(p<.001)和残疾风险(p<.001至p=.033)相关。第一周内CRIB降低代表病情改善,与各不良结局风险降低独立相关,p<.05。
在第一周内,CRIB可靠、有效且具有反应性。这些特性支持在队列研究中使用CRIB对婴儿进行风险和疾病严重程度分层,也表明CRIB未来可能有其他用途。